检索规则说明:AND代表“并且”;OR代表“或者”;NOT代表“不包含”;(注意必须大写,运算符两边需空一格)
检 索 范 例 :范例一: (K=图书馆学 OR K=情报学) AND A=范并思 范例二:J=计算机应用与软件 AND (U=C++ OR U=Basic) NOT M=Visual
作 者:赵健[1] 刘晓程[1] 孔祥荣[1] 王颖[1] 史蓉芳[1] 赵晓斌[1] 刘天军[2] 吕丰[2]
机构地区:[1]中国医学科学院中国协和医科大学泰达国际心血管病医院心外科,天津300457 [2]中国医学科学院中国协和医科大学生物医学工程研究所分子设计实验室,天津300193
出 处:《心脏杂志》2009年第3期383-386,共4页Chinese Heart Journal
基 金:天津市科技发展计划项目资助(05YFGZSF02900)
摘 要:目的探讨高分子缓释降解材料聚乳酸/乙醇酸(poly D,L-lactic/glycolic acid,PLGA)联合碱性成纤维细胞生长因子(basic fibroblast growth factor,bFGF),对心肌缺血区域灌注改善的情况。方法成功建立小型猪急性心肌梗死模型后随机分至空白对照组、PLGA支架对照组和PLGA复合bFGF支架组;6周后,SPECT结合软件EmoryCardiac Toolbox分析灌注缺损区域质量百分率的变化,超声学指标LVEDD、LVEDS、FS%评价心脏功能,Image ProPlus软件量化各组新生血管密度。结果6周后PLGA复合bFGF支架组新生血管密度、心肌灌注质量缺损百分率与空白对照组、PLGA支架对照组有显著差异(P<0.01),PLGA复合bFGF支架组FS%较空白对照组、PLGA支架对照组显著改善(P<0.05)。结论bFGF联合PLGA缓释材料能够显著增加新生血管密度,改善缺血部位心肌血流灌注,进而提高心脏功能。AIM To investigate the effects of degradable poly D, L-lactic/glycolic acid (PLGA) with basic fibroblast growth factor (bFGF) on promoting myocardial revascularization. METHODS Miniswines with acute myocardial infarction were randomly assigned to control group, blank PLGA stent group and PLGA stent with bFGF group. Six weeks postoperatively, quantitative analysis of new vessels was performed by Image Pro Plus software. The mass defect percent of myocardial perfusion was calculated by Emory Cardiac Toolbox software. LVEDd, LVEDs and FS% reflective of cardiac function were meas- ured by echocardiology. RESULTS Six weeks postoperatively, both new vessels density and mass defect percent in PLGA stent with bFGF group showed significant difference compared with those in control group and blank PLGA stent group (P 〈0. O1 ). FS% in PLGA stent with bFGF group was significantly enhanced compared with that in the other two groups (P 〈 0. 05). CONCLUSION bFGF combined with degradable PLGA stent increases new vessel's density, improves myocardial perfusion and enhances cardiac function.
分 类 号:R541.4[医药卫生—心血管疾病]
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在载入数据...
正在链接到云南高校图书馆文献保障联盟下载...
云南高校图书馆联盟文献共享服务平台 版权所有©
您的IP:216.73.216.222